Postoperative Pain Management for Patellar Tendon Repair
For a patient status post patellar tendon repair staying overnight in the hospital, order a multimodal regimen consisting of scheduled acetaminophen (1000 mg every 6 hours), an NSAID (if no contraindications), and immediate-release oral opioids (morphine 10-15 mg or oxycodone 5-10 mg every 4 hours as needed) for breakthrough pain. 1, 2, 1
Multimodal Analgesia Framework
The cornerstone of postoperative pain management after orthopedic surgery is multimodal analgesia, which combines medications with different mechanisms of action to provide superior pain relief while minimizing opioid-related side effects 1, 3.
First-Line: Scheduled Non-Opioid Analgesics
Acetaminophen (Paracetamol):
- Dose: 1000 mg every 6 hours (maximum 4000 mg/24 hours)
- Route: Oral preferred; IV acetaminophen acceptable but offers no clinical advantage over oral 4
- Rationale: Strong evidence supports acetaminophen in multimodal regimens for reducing opioid consumption, decreasing opioid-related complications, and shortening hospital stays 1. This is particularly well-documented in orthopedic surgery populations 1.
NSAIDs (if no contraindications):
- Options: Ibuprofen 600 mg every 6 hours OR Ketorolac 15-30 mg IV/IM every 6 hours
- Caution: Avoid in patients with renal insufficiency, GI bleeding risk, or cardiovascular disease 5, 1
- Rationale: NSAIDs reduce morphine consumption and related side effects when used in multimodal analgesia 1. The combination of acetaminophen plus NSAID provides superior analgesia compared to either agent alone 4.
Second-Line: Opioids for Breakthrough Pain
Immediate-release opioids are preferred over long-acting formulations for acute postoperative pain 2:
Morphine (preferred): 10-15 mg oral every 4 hours PRN
Oxycodone (alternative): 5-10 mg oral every 4 hours PRN 6, 7
Hydromorphone: 2-4 mg oral every 4-6 hours PRN (for patients with morphine intolerance) 6
Critical prescribing principles:
- Use immediate-release formulations only 2
- Avoid modified-release or transdermal opioid preparations, as they are associated with harm in acute postoperative settings 2
- Prescribe PRN (as needed) rather than scheduled dosing to minimize total opioid exposure 2
- Adjust doses for elderly patients (>70 years) and those with renal impairment 2
Monitoring and Safety
Essential monitoring parameters:
- Pain scores using numerical rating scale (0-10) every 4 hours 3
- Sedation scores in addition to respiratory rate to detect opioid-induced ventilatory impairment 2
- Recognition that escalating pain may indicate surgical complications (compartment syndrome, infection) rather than inadequate analgesia 2
Common pitfall: Do not use pain scores in isolation to guide opioid administration. Comprehensive pain assessment is required, and repeated elevated pain scores should trigger clinical re-evaluation rather than automatic opioid escalation 2.
Transition to Oral Route
Switch to oral medications as soon as the patient can tolerate oral intake 2. The oral route is preferred for all analgesics in the postoperative ward setting.
Weaning Strategy
When pain improves, follow a reverse analgesic ladder 2:
- First: Wean and discontinue opioids
- Second: Stop NSAIDs
- Last: Stop acetaminophen
Discharge Planning
For overnight admission with next-day discharge:
- Prescribe no more than 5-7 days of opioids 2
- Provide separate prescriptions for opioids and non-opioids to allow independent dose adjustments 2
- Ensure adequate supply of acetaminophen and NSAIDs for home use 2
- Educate on safe opioid storage, disposal, and avoidance of driving/machinery 2
Special Considerations for Patellar Tendon Repair
While regional anesthesia (femoral or adductor canal blocks) may have been used intraoperatively 8, the focus for floor orders is systemic analgesia. The multimodal approach described above is appropriate for this orthopedic procedure and aligns with evidence from similar lower extremity surgeries 1.
Avoid gabapentinoids (gabapentin/pregabalin) for routine postoperative pain, as evidence shows no significant benefit over placebo with additional concerns for sedation and respiratory depression 4.